Glisoxepide Explained

Glisoxepide (INN) is an orally available anti-diabetic drug from the group of sulfonylureas.[1] It belongs to second-generation sulfonylureas.[2]

Notes and References

  1. Haupt E, Köberich W, Beyer J, Schöffling K . Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects . Diabetologia . 7 . 6 . 449–54 . December 1971 . 5004178 . 10.1007/bf01212061. free .
  2. Loubatières. A. Ribes. G. Mariani. MM. Alric. R. Pharmacological Comparison Between Tolbutamide and Two Second Generation Hypoglycemic Sulfonylureas (Glibenclamide and Glisoxepide). Acta Diabetologica Latina. 10. 2. 261–82. 4200420. 10.1007/bf02590661. 1973.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Glisoxepide".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.